Anthony Di Roio

2PUBLICATIONS
3CO-AUTHORS
Molecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Nov 08, 2023
MDR1-EXPRESSING CD4+ T CELLS WITH TH1.17 FEATURES RESIST TO NEOADJUVANT CHEMOTHERAPY AND ARE ASSOCIATED WITH BREAST CANCER CLINICAL RESPONSE.

Anthony Di Roio, Margaux Hubert, Laurie Besson

|Apr 30, 2021
Recruitment and Expansion of Tregs Cells in the Tumor Environment-How to Target Them?

Justine Cinier, Margaux Hubert, Laurie Besson

Pageof 1